Back to top

Tale of the Tape

Zacks Equity Research

Catalyst Pharmaceutical Partners, Inc. Enters Oversold Territory

CPRX

Trades from $3
Read Full ArticleHide Full Article

Catalyst Pharmaceutical Partners, Inc.’s (CPRX - Free Report) share price has entered into oversold territory with an RSI value of 25.81. The Zacks Consensus Estimate on Catalyst Pharmaceutical Partners, Inc.’s earnings for the full year period has loss of 0.01 cents over the past two months to $-0.25 per share. Currently, Catalyst Pharmaceutical Partners, Inc. is a Zacks #1 Rank (“Strong Buy”), suggesting that now might be a good time to get in on (CPRX - Free Report) after its recent drop.




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>